Crescita Therapeutics (TSE:CTX) Trading 5.4% Higher – Should You Buy?

Crescita Therapeutics Inc. (TSE:CTX)’s share price shot up 5.4% during trading on Monday . The stock traded as high as C$0.60 and last traded at C$0.59. 20,875 shares traded hands during trading, an increase of 102% from the average session volume of 10,325 shares. The stock had previously closed at C$0.56.

Crescita Therapeutics Trading Up 5.4 %

The company has a 50 day moving average of C$0.56 and a 200 day moving average of C$0.58. The firm has a market cap of C$10.86 million, a price-to-earnings ratio of -4.01 and a beta of 1.69. The company has a current ratio of 2.70, a quick ratio of 2.29 and a debt-to-equity ratio of 5.77.

Insider Buying and Selling at Crescita Therapeutics

In other news, Director Jose Darocha acquired 86,000 shares of the company’s stock in a transaction dated Friday, December 27th. The stock was bought at an average price of C$0.60 per share, with a total value of C$51,436.60. Company insiders own 10.87% of the company’s stock.

Crescita Therapeutics Company Profile

Crescita Therapeutics Inc, a dermatology company, provides non-prescription skincare products and prescription drug products in Canada, the United States, and internationally. The company operates through three segments: Commercial Skincare, Licensing and Royalties, and Manufacturing and Services. It owns proprietary platform technologies, including Multiplexed Molecular Penetration Enhancers (MMPE) and DuraPeel for the development of topicals containing cannabis and hemp.